Sign In
Buy SITC
$4.88
-0.0500 (-1.01%)
At Close: Jun 03, 2026
Carisma Therapeutics Announces Upcoming Presentations at SITC 2024
09:05am, Friday, 04'th Oct 2024
PHILADELPHIA , Oct. 4, 2024 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and developing inn
Xilio Therapeutics Announces Upcoming Poster Presentation at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting
09:05am, Friday, 04'th Oct 2024
WALTHAM, Mass., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies fo
VANCOUVER, British Columbia--(BUSINESS WIRE)---- $ABCL--AbCellera Announces Presentation on T-cell Engager Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024.
SOUTH SAN FRANCISCO, Calif., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical‑stage T-cell reprogramming company advancing a diverse pipeline of cell therapies f
Werewolf Therapeutics to Present Posters at the Society for Immunotherapy of Cancer's (SITC) 39th Annual Meeting
09:00am, Friday, 04'th Oct 2024
WATERTOWN, Mass., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development
BOSTON, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and mod
IO Biotech Announces Two Poster Presentations at the Society for Immunotherapy of Cancer's (SITC) 39th Annual Meeting
09:00am, Friday, 04'th Oct 2024
NEW YORK, Oct. 04, 2024 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, off-the-shelf, immune-modulating therapeutic cancer vaccines based o
Candel Therapeutics to Present Preclinical Data on Therapeutic Potential of CAN-3110 in Melanoma at SITC 2024 Annual Meeting
09:00am, Friday, 04'th Oct 2024
NEEDHAM, Mass., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biologic
Curbline Properties Announces Tax Basis
06:31am, Friday, 04'th Oct 2024
NEW YORK--(BUSINESS WIRE)--On October 1, 2024, Curbline Properties Corp. (NYSE: CURB) (“CURB” or “Curbline”) completed its separation from SITE Centers Corp. (NYSE: SITC) (“SITC”) and beca
SITC Closes Curbline Spin-Off, Disposes Properties Worth $610.1M
02:36pm, Tuesday, 01'st Oct 2024
SITE Centers announces completion of Curbline spinoff. It also provides an update on its transaction activity from Sept.
SITE Centers: Curbline Properties IPO Prices In Line With Valuations
11:47am, Tuesday, 01'st Oct 2024
SITE Centers Corp. is a retail REIT focused on retail locations close to residents with a high household income. The company successfully spun off its premium assets in a new REIT called Curbline Prop
SITE Centers Announces Completion of Spin-Off of Curbline Properties
06:30am, Tuesday, 01'st Oct 2024
BEACHWOOD, Ohio--(BUSINESS WIRE)--SITE Centers Corp. (NYSE: SITC) (the “Company” or “SITE Centers”) today announced that it has completed the previously announced spin-off of Curbline Properti
SITE Centers Provides Transaction and Curbline Balance Sheet Update
06:59am, Monday, 30'th Sep 2024
BEACHWOOD, Ohio--(BUSINESS WIRE)--SITE Centers Corp. (NYSE: SITC) (the “Company” or “SITE Centers”), an owner of open-air shopping centers in suburban, high household income communities, today
SITE Centers Disposes Shopping Centers for $714M, Acquires for $111M
02:01pm, Wednesday, 18'th Sep 2024
SITC provides an update on its transaction and financing activities in Q3 2024 through Sept. 17, 2024, which displays its prudent capital-management practices.
Shopping Center REITs Are Hot: Pick A Winner
08:00am, Monday, 09'th Sep 2024
The current environment is favorable for REITs, with normalized prices, falling Treasury yields, and expected prime rate cuts. Shopping Center REITs offer above-average yields (3.88%) and superior gro
